Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Apr. 02, 2022   388,298,375      
Beginning balance at Apr. 02, 2022 $ 3,530,355 $ 97,075 $ 3,916,384 $ (926,579) $ 443,475
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 118,584       118,584
Dividends on Common Stock (702,846)   (203,394)   (499,452)
Stock-based compensation, net (in shares)   367,156      
Stock-based compensation, net 57,559 $ 91 62,989   (5,521)
Foreign currency translation and other (108,019)     (108,019)  
Defined benefit pension plans 62,598     62,598  
Derivative financial instruments (47,518)     (47,518)  
Ending balance (in shares) at Apr. 01, 2023   388,665,531      
Ending balance at Apr. 01, 2023 2,910,713 $ 97,166 3,775,979 (1,019,518) 57,086
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (968,882)       (968,882)
Dividends on Common Stock (303,140)   (246,054)   (57,086)
Stock-based compensation, net (in shares)   170,688      
Stock-based compensation, net 64,487 $ 43 70,146   (5,702)
Foreign currency translation and other (8,788)     (8,788)  
Defined benefit pension plans (14,641)     (14,641)  
Derivative financial instruments $ (21,384)     (21,384)  
Ending balance (in shares) at Mar. 30, 2024 388,836,219 388,836,219      
Ending balance at Mar. 30, 2024 $ 1,658,365 $ 97,209 3,600,071 (1,064,331) (974,584)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (189,716)       (189,716)
Dividends on Common Stock (140,165)   (140,165)    
Stock-based compensation, net (in shares)   858,980      
Stock-based compensation, net 72,284 $ 215 80,780   (8,711)
Foreign currency translation and other 47,250     47,250  
Defined benefit pension plans 2,286     2,286  
Derivative financial instruments $ 37,055     37,055  
Ending balance (in shares) at Mar. 29, 2025 389,695,199 389,695,199      
Ending balance at Mar. 29, 2025 $ 1,487,359 $ 97,424 $ 3,540,686 $ (977,740) $ (1,173,011)